Ryuji Maekawa

1.4k total citations
51 papers, 1.2k citations indexed

About

Ryuji Maekawa is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ryuji Maekawa has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Ryuji Maekawa's work include Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (13 papers) and Peptidase Inhibition and Analysis (9 papers). Ryuji Maekawa is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (13 papers) and Peptidase Inhibition and Analysis (9 papers). Ryuji Maekawa collaborates with scholars based in Japan, United States and Tunisia. Ryuji Maekawa's co-authors include Takayuki Yoshioka, Kenji Sugita, Kanji Hojo, Kenji Kawada, Masahiro Fuji, Yoshinori Tamura, Ken Yasui, Takuji Nakatani, Fumihiko Watanabe and Hiroshige Tsuzuki and has published in prestigious journals such as Cancer Research, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Ryuji Maekawa

51 papers receiving 1.2k citations

Peers

Ryuji Maekawa
David V. Gold United States
Takayuki Yoshioka Japan
Damian Grobelny United States
Alan H. Davidson United Kingdom
Isaiah J. Fidler United States
W. E. Berdel Germany
Varvara Petrova Italy
Kylie A. Hotchkiss United States
Sachi Horibata United States
Veronica C. Ardi United States
David V. Gold United States
Ryuji Maekawa
Citations per year, relative to Ryuji Maekawa Ryuji Maekawa (= 1×) peers David V. Gold

Countries citing papers authored by Ryuji Maekawa

Since Specialization
Citations

This map shows the geographic impact of Ryuji Maekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Maekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Maekawa more than expected).

Fields of papers citing papers by Ryuji Maekawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuji Maekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Maekawa. The network helps show where Ryuji Maekawa may publish in the future.

Co-authorship network of co-authors of Ryuji Maekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuji Maekawa. A scholar is included among the top collaborators of Ryuji Maekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuji Maekawa. Ryuji Maekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsushita, Hirokazu, Akihiro Hosoi, Satoshi Ueha, et al.. (2014). Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest. Cancer Immunology Research. 3(1). 26–36. 88 indexed citations
2.
Yoshikawa, Toshiaki, et al.. (2014). Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy. International Journal of Oncology. 45(5). 1847–1856. 9 indexed citations
3.
Kaneko, Toru, Mariko Saito, Kazuro Iwai, et al.. (2013). Impaired and imbalanced cellular immunological status assessed in advanced cancer patients and restoration of the T cell immune status by adoptive T-cell immunotherapy. International Immunopharmacology. 18(1). 90–97. 29 indexed citations
4.
Kamigaki, Takashi, et al.. (2013). Zoledronate-pulsed dendritic cell-based anticancer vaccines. OncoImmunology. 2(9). e25636–e25636. 6 indexed citations
5.
Hosoi, Akihiro, Satoshi Ueha, Makoto Kurachi, et al.. (2008). Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination. Biochemical and Biophysical Research Communications. 371(2). 242–246. 9 indexed citations
6.
Murakami, Nobutoshi, et al.. (2004). New analogue of arenastatin A, a potent cytotoxic spongean depsipeptide, with anti-tumor activity. Bioorganic & Medicinal Chemistry Letters. 14(10). 2597–2601. 12 indexed citations
7.
Matsumura, Kiichiro, Ken Arai, Di Zhong, et al.. (2003). Disruption of dystroglycan axis by β-dystroglycan processing in cardiomyopathic hamster muscle. Neuromuscular Disorders. 13(10). 796–803. 13 indexed citations
8.
9.
Maki, Hideo, et al.. (2002). Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11. Clinical & Experimental Metastasis. 19(6). 519–526. 9 indexed citations
10.
Matsumoto, Mitsunobu, et al.. (2002). Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer. Cancer Letters. 182(1). 61–68. 1 indexed citations
11.
Matsumoto, Mitsunobu, et al.. (2001). Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer. Japanese Journal of Cancer Research. 92(1). 51–58. 16 indexed citations
12.
Yamada, Hajime, et al.. (2001). Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel. Cancer Letters. 172(1). 17–25. 19 indexed citations
13.
Hamana, Hiroshi, et al.. (2000). Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan‐peptide‐doxorubicin Conjugates. Japanese Journal of Cancer Research. 91(12). 1333–1338. 8 indexed citations
14.
Yoshida, Hiroshi, et al.. (1999). Combination Chemotherapy with Nedaplatin and Cyclophosphamide in Human Ovarian Cancer Model. Japanese Journal of Cancer Research. 90(8). 887–894. 7 indexed citations
15.
Uchida, Naoshige, et al.. (1998). Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.. PubMed. 18(1A). 247–52. 21 indexed citations
16.
17.
Maekawa, Ryuji, Y Kishimoto, Kosaburo Sato, & Morio Homma. (1993). Establishment of highly metastatic tumor clones derived from a skin squamous cell carcinoma (SqC-NH), D-1 and F-3, with distinct features of pulmonary metastases. Clinical & Experimental Metastasis. 11(4). 343–353. 4 indexed citations
18.
Löhr, Matthias, et al.. (1992). Human cytomegalovirus in the pancreas of patients with type 2 diabetes: Is there a relation to clinical features, mRNA and protein expression of insulin, somatostatin, and MHC class II?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 421(5). 371–378. 7 indexed citations
19.
Maekawa, Ryuji, et al.. (1988). Distinct Antitumor Mechanisms of Recombinant Murine Interferon-γ Against Two Murine Tumor Models. Journal of Interferon Research. 8(2). 227–239. 12 indexed citations
20.
Maekawa, Ryuji, et al.. (1988). Differential Efficacies of Recombinant Murine Interferon-γ and Recombinant Human Interleukin 2 Against EL4-Bearing Mice. Journal of Interferon Research. 8(2). 241–249. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David V. Gold Breakdown of academic impact, for papers by Takayuki Yoshioka Breakdown of academic impact, for papers by Damian Grobelny Breakdown of academic impact, for papers by Alan H. Davidson Breakdown of academic impact, for papers by Isaiah J. Fidler Breakdown of academic impact, for papers by W. E. Berdel Breakdown of academic impact, for papers by Varvara Petrova Breakdown of academic impact, for papers by Kylie A. Hotchkiss Breakdown of academic impact, for papers by Sachi Horibata Breakdown of academic impact, for papers by Veronica C. Ardi
Rankless by CCL
2026